Focus on research, not regulations.
通过见解驱动策略王者荣耀kpl外围投注
IQVIA's Regulatory Affairs approach integrates technology, analytics, and insights built from years of experience to help biopharma companies exceed global compliance goals, reduce costs and get drugs to market faster.
我们的产品涵盖了药物开发的连续性，在制定监管战略和发展计划方面，我们的协助有助于消除惊喜，保持开发的步伐并确保在每一步中确保适当的质量策略。
Enhance productivity through automation
Intelligent systems, robotic process automation and mobile access are changing what’s possible. IQVIA gives you turnkey access to business-transforming technology, including
- Document comparison tools that make diagnostic efforts easier
- Structured content authoring capabilities to help manage data in submissions
- 自动化重复，高功能，低复杂任务
At IQVIA, we are also combining multiple capabilities into customized expert systems to enhance productivity to help reduce the burden of administrative tasks.
Regulatory compliance
Automate and streamline your regulatory management from correspondence to commitments to registration and tracking.
Reduce risk throughout product lifecycles
Enhance patient safety and study quality by using data, analytics, and technology to monitor patient, site, and study performance with risk-based and centralized monitoring.
Use AI, machine learning, NLP and new technologies to streamline pharmacovigilance, improve efficiencies, reduce costs, and meet safety demands.
通过一系列医学写作服务在监管文件中创建透明度，可在整个产品开发生命周期内提供质量和及时性。
利用自动化的力量执行简化的端到端安全解决方案，同时降低成本。
自动化和标准化您的监管管理，从对登记和跟踪的信件和承诺。
Partner with compliance experts to create, implement and manage efficient, end-to-end processes that ensure your organization is compliant with global engagement and transparency regulations and codes.